Evidence map›Paper›PMID 10954581›Full record

ArticleJournal of virology2000

The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.

M Alfano, T Pushkarsky, G Poli, M Bukrinsky

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages.Frontiers in cellular and infection microbiology · 2021
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. CD147 stimulates HIV-1 infection in a signal-independent fashion.Biochemical and biophysical research communications · 2007
    Article
  12. Viral hijacking of G-protein-coupled-receptor signalling networks.Nature reviews. Molecular cell biology · 2004
    Review
  13. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M AlfanoThe Picower Institute for Medical Research, Manhasset, New York 11030, USA.
T Pushkarsky
G Poli
M Bukrinsky
Vita-Salute San Raffaele University · IT

Funding

MECHANISMS OF HIV--INDUCED DYSREGULATION OF MONOCYTESR01AI038245 · NIAID · PICOWER INSTITUTE FOR MEDICAL RESEARCH · PI BUKRINSKY, MICHAEL ILYA · 1996 to 1998
–
NIAID NIH HHS R01 AI 38245
6 · The paper itself

Abstract

We have recently demonstrated that the binding subunit (B-oligomer) of pertussis toxin (PTX-B) deactivates CCR5 and inhibits entry of R5 human immunodeficiency virus type 1 (HIV-1) strains in activated primary T lymphocytes (M. Alfano et al., J. Exp. Med. 190:597-605, 1999). We now present evidence that PTX-B also affects a post-entry step of HIV-1 replication. While PTX-B inhibited fusion induced by R5 but not that induced by X4 envelopes, it blocked infection of T cells with recombinant HIV-1 particles pseudotyped with R5, X4, and even murine leukemia virus or vesicular stomatitis virus envelopes. It also suppressed HIV-1 RNA synthesis in cultures of infected peripheral blood mononuclear cells when new infections had been inhibited by zidovudine, and it reduced Tat-dependent expression of the luciferase reporter gene controlled by the HIV-1 long terminal repeat (LTR). Surprisingly, PTX-B did not affect expression from the cytomegalovirus promoter, nor did it reduce the basal (Tat-independent) expression from the LTR promoter. These results indicate that PTX-B inhibits HIV-1 infection at both the entry and the post-entry stages of viral replication, with the post-entry activity specifically affecting transcription or stability of Tat-stimulated HIV-1 mRNAs.

Indexed as

Pertussis ToxinCells, CulturedCytomegalovirusGene Products, tatHIV-1HIV Long Terminal RepeatHumansLeukemia Virus, MurineLeukocytes, MononuclearMembrane FusionPolymersPromoter Regions, GeneticRecombinant Proteinstat Gene Products, Human Immunodeficiency VirusT-LymphocytesVesicular stomatitis Indiana virusGene Products, tatPertussis ToxinPolymersRecombinant Proteinstat Gene Products, Human Immunodeficiency VirusViral Envelope ProteinsVirulence Factors, Bordetella

Identifiers

PMID10954581
PMCPMC116391
OpenAlexW2128193661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.